Results 31 to 40 of about 2,277,128 (298)

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease

open access: yesHepatology, EarlyView., 2022
Increased liver content of DHA‐derived small lipid autacoids (i.e resolvin D1 and maresin 1) associates with enhanced mitochondrial oxidative phosphorylation, fatty acid β‐oxidation and bioenergetic metabolic flux. These features provide hepatic protection from steatotic, pro‐inflammatory and fibrogenic insults.
Cristina López‐Vicario   +12 more
wiley   +1 more source

Ten years of the WHO Framework Convention on Tobacco Control: progress in the Americas

open access: yesSalud Pública de México, 2017
The objective of this article is to analyze the progress made in the Americas in the implementation of the World Health Organization Framework Convention on Tobacco Control (FCTC) after its tenth anniversary of entry into force.
Adriana Blanco   +3 more
doaj   +1 more source

Attacking the public health crisis of hepatocellular carcinoma at its roots

open access: yesHepatology, EarlyView., 2022
Abstract As the third most common cause of cancer‐related death worldwide with significant mortality rates in the United States, hepatocellular carcinoma has strong association with cirrhosis and chronic hepatitis B virus (HBV) with a growing at‐risk population from the rise in chronic liver disease from alcohol use and nonalcoholic fatty liver disease.
Hannah M. Lee   +3 more
wiley   +1 more source

Noncommunicable diseases in the Americas: a review of the Pan American Health Organization’s 25-year program of work

open access: yesRevista Panamericana de Salud Pública, 2023
This article describes progress in tackling noncommunicable diseases (NCDs) in the Americas since the Pan American Health Organization (PAHO) started its NCD program 25 years ago. Changes in the epidemiology of NCDs, NCD policies, health service capacity,
Silvana Luciani   +14 more
doaj   +1 more source

An Architecture Proposal for Noncommunicable Diseases Prevention

open access: yesProcedia Computer Science, 2023
Noncommunicable Diseases (NCDs) are a leading global health challenge, causing 41 million deaths per year. Risk factors include genetics, environmental factors, and lifestyle choices. Adopting healthy lifestyles can prevent or delay the onset of NCDs, but health misinformation can lead people to make poor decisions about their health.
Diana Braga   +4 more
openaire   +2 more sources

Definition of noncommunicable diseases and injuries.

open access: yes, 2017
Definition of noncommunicable diseases and injuries.
Hae Hyuk Jung (3713233)   +1 more
core   +1 more source

Biological risk factors for noncommunicable diseases among university employees (n = 613).

open access: yes, 2022
Biological risk factors for noncommunicable diseases among university employees (n = 613).
Trevino A. Pakasi (12800279)   +4 more
core   +1 more source

Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2015
The 18th WHO Global Tuberculosis Annual Report indicates that there were an estimated 8.6 million incident cases of tuberculosis (TB) in 2012, which included 2.9 million women and 530,000 children. TB caused 1.3 million deaths including 320,000 human immunodeficiency virus (HIV)-infected people; three-quarters of deaths occurred in Africa and Southeast
Matthew Bates   +2 more
openaire   +3 more sources

Dietary Fats and Chronic Noncommunicable Diseases [PDF]

open access: yesNutrients, 2018
The role of dietary fat has been long studied as a modifiable variable in the prevention and treatment of noncommunicable cardiometabolic disease. Once heavily promoted to the public, the low-fat diet has been demonstrated to be non-effective in preventing cardiometabolic disease, and an increasing body of literature has focused on the effects of a ...
Hayley E. Billingsley   +2 more
openaire   +5 more sources

Thymosin Alpha‐1 Provides Direct Neuroprotection by Engaging the Orexin Receptor HCRTR1 to Suppress Neuronal Necroptosis

open access: yesAdvanced Science, EarlyView.
In this study, we unveil a thymus‐brain endocrine axis wherein Tα1 engages HCRTR1 to inhibit RIPK3‐mediated necroptosis. This study nominates the Tal‐HCRTR1‐RIPK3 axis as a potent and clinically translatable therapeutic target for stroke and neurodegeneration.
Xinmei Kang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy